Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Derek Mires"'
Autor:
Neeraj Agarwal, Jason Li, Nicole Hagner, Margaret M. Woo, Martijn P. Lolkema, Sunil Sharma, Emile E. Voest, Petronella O. Witteveen, Maria Grazia Porro, Dagmar Hess, Derek Mires, Sue-zette Valera
Publikováno v:
Blood. 118:5001-5001
Abstract 5001 Panobinostat is a potent class I/II/IV oral pan-deacetylase inhibitor which has shown promising clinical activity in patients with multiple myeloma and myelofibrosis, some with compromised renal and hepatic functions. The metabolism med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e465722091f5c5f22494e4c3b1b8cc51
https://doi.org/10.1182/blood.v118.21.5001.5001
https://doi.org/10.1182/blood.v118.21.5001.5001
Autor:
Li-An Xu, Cedric E. Dos Santos, Alexander E. Perl, Nigel H. Russell, Jorge E. Cortes, Hiroyuki Sumi, Derek E. Mires, Alwin Krämer, Mark J. Levis, Ken C. Chang, Flora Berisha, Aziz Benzohra, Yuhu Yan, Giovanni Martinelli, Kazunobu Kato, Samer K. Khaled, Arnaud Lesegretain, Sergey Korkhov, Takeshi Isoyama, Siddhartha Ganguly, Tobias Günnel
Publikováno v:
Cancer Research. 80:784-784
Introduction: We evaluated the impact of baseline (BL) co-mutations and FLT3-ITD VAF on overall survival (OS) and response (composite complete remission [CRc]) to quizartinib and SC in the phase III QuANTUM-R trial. Methods: We analyzed 37 recurrentl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b62a012e2869437484c5a96bd16958d
https://doi.org/10.1158/1538-7445.am2020-784
https://doi.org/10.1158/1538-7445.am2020-784